IFI6 and COVID-19: Compared to normal tissues, IFI6 is markedly upregulated in white blood cells from COVID-19 patients and nasopharyngeal tissues infected with SARS-COV-2 and is associated with antiviral immune modulation and clinical progression (Dong et al., 2022; Sun et al., 2023; Villamayor et al., 2023).